Renal ablation electrode with force-activatable conduction apparatus

ABSTRACT

An electrode is provided at a distal end of a catheter and dimensioned for deployment within a renal artery. A deformable cover of the electrode incorporates a force-activatable conduction apparatus. The cover is configured to conduct electrical energy only through a region or regions of the cover subject to deformation due to contact with a wall of the target vessel. The electrical energy is sufficient to ablate perivascular renal nerves proximate the deformed region or regions of the electrode cover. The cover is configured to prevent conduction of electrical energy through the cover in the absence of a deformation force applied to the cover.

RELATED PATENT DOCUMENTS

This application claims the benefit of Provisional Patent Application Ser. No. 61/415,940 filed Nov. 22, 2010, to which priority is claimed pursuant to 35 U.S.C. §119(e) and which are hereby incorporated herein by reference.

SUMMARY

Embodiments of the disclosure are directed to apparatuses and methods for ablating target tissue of the body, such as perivascular renal nerves. According to various embodiments, a catheter includes a flexible shaft having a proximal end, a distal end, and a length sufficient to access a target vessel of the body relative to a percutaneous access location. A conductor arrangement extends along the shaft between the proximal and distal ends of the shaft. An electrode is provided at the distal end of the shaft, coupled to the conductor arrangement, and dimensioned for deployment within the target vessel. A deformable cover is provided at the electrode and incorporates a force-activatable conduction apparatus. The cover is configured to conduct electrical energy only through a region or regions of the cover subject to deformation due to contact with a wall of the target vessel. The electrical energy is sufficient to ablate target tissue proximate the deformed region or regions of the cover. The cover is configured to prevent conduction of electrical energy through the cover in the absence of a deformation force applied to the cover.

According to some embodiments, a catheter includes a flexible shaft having a proximal end, a distal end, and a length sufficient to access a patient's renal artery relative to a percutaneous access location. A conductor arrangement extends along the shaft between the proximal and distal ends of the shaft. An electrode is provided at the distal end of the shaft, coupled to the conductor arrangement, and dimensioned for deployment within the renal artery. A deformable cover is provided at the electrode and incorporates a force-activatable conduction apparatus. The cover is configured to conduct electrical energy only through a region or regions of the cover subject to deformation due to contact with a wall of the renal artery. The electrical energy is sufficient to ablate perivascular renal nerves proximate the deformed region or regions of the cover. The cover is configured to prevent conduction of electrical energy through the cover in the absence of a deformation force applied to the cover.

In accordance with other embodiments, a method of ablating tissue of the body involves situating an electrode comprising a deformable cover within a target vessel, deforming one or more regions of the cover in response to forcing the cover against a wall of the target vessel, and conducting ablative electrical energy only through the one or more deformed cover regions and into target tissue proximate the one or more deformed cover regions. The method also involves preventing conduction of ablative electrical energy through the cover in the absence of cover deformation. In some embodiments, the target vessel is a renal artery, and the target tissue comprises perivascular renal nerves.

These and other features can be understood in view of the following detailed discussion and the accompanying drawings.

BRIEF DESCRIPTION OF THE DRAWINGS

FIG. 1 is an illustration of a right kidney and renal vasculature including a renal artery branching laterally from the abdominal aorta;

FIGS. 2A and 2B illustrate sympathetic innervation of the renal artery;

FIG. 3A illustrates various tissue layers of the wall of the renal artery;

FIGS. 3B and 3C illustrate a portion of a renal nerve;

FIG. 4 is a flow chart showing various processes for ablating target tissue of the body, such as perivascular renal nerves, in accordance with various embodiments;

FIGS. 5 and 6A-6B illustrate an arrangement including an electrode and a deformable electrode cover that incorporates a force-activatable conduction apparatus in accordance with various embodiments;

FIGS. 7 and 8 illustrate an arrangement including an electrode and a deformable electrode cover that incorporates a force-activatable conduction apparatus in accordance with various embodiments;

FIGS. 9 illustrate an arrangement including an electrode and a deformable electrode cover that incorporates a force-activatable conduction apparatus in accordance with various embodiments;

FIGS. 10-11 illustrate an arrangement including an electrode and a deformable electrode cover that incorporates a force-activatable conduction apparatus in accordance with various embodiments; and

FIG. 12 shows a representative renal denervation apparatus in accordance with various embodiments.

DETAILED DESCRIPTION

Embodiments of the disclosure are directed to apparatuses and methods for ablating target tissue of the body from within a vessel. Embodiments of the disclosure are directed to apparatuses and methods for ablating perivascular renal nerves from within the renal artery for the treatment of hypertension. Embodiments of the disclosure are directed to renal ablation methodologies that provide for a reduction in wasted energy, and a reduction in the cooling required to protect the renal artery during ablation.

When performing renal artery-based radiofrequency (RF) ablation of perivascular renal nerves, a substantial amount of the energy passes through the blood rather than through the artery wall and to the target nerve tissue. This energy is wasted since it does not contribute to nerve ablation, and can make cooling to protect the artery wall more difficult. For example, conventional approaches to RF ablation via the renal artery waste significant energy by conduction from the RF electrode to the blood rather than the artery and target tissue, which can cause coagulation and embolic complications.

Embodiments of the disclosure are directed to apparatuses and methods that prevent or reduce unwanted energy passage from RF electrodes to blood and non-targeted tissues during RF ablation of perivascular renal nerves. Various embodiments are directed to an electrode which includes a deformable cover that incorporates a force-activatable conduction apparatus. According to embodiments of the disclosure, a portion of an ablation catheter electrode includes a force-responsive-conductivity cover. In one embodiment, a thin segmented cover is made up of many areas or segments including semiconductor material separated by insulating material.

Each segment functions like a solid-state switching structure, with a collector and an emitter at the inside and outside surfaces, and a base in between. Each segment of the cover can pass current from the inside to the outside surfaces only when a voltage is applied to that portion of the cover. Each segment also includes an electroactive material which creates voltage when a force is exerted by contact with the artery wall. The voltage output from the electroactive material is passed as input to the base of the transistor-like structure. Together, the cover components create an insulating cover that conducts electrical energy for tissue ablation only where it is pressed against the artery wall, and other portions of the cover do not conduct electrical energy to the blood. The power requirements and cooling requirements are greatly reduced by only conducting the energy where it is useful. Also, reduced charring and less coagulum and debris embolization is achieved.

In other embodiments, an RF electrode includes a deformable covering with conductive particles in a nonconductive matrix. The conductive particles can be metal beads, for example, and the nonconductive matrix can be a silicone gel, for example. In some embodiments, the conductive particles may define microspheres having a non-conductive grease-like surface. When the RF electrode cover is pressed against the artery wall, the contacting side of the cover is deformed, displacing the gel until the metal beads contact each other. The portion of the cover that is deformed by pressing against the artery wall passes current through the cover to the artery wall, and other portions of the cover that are not deformed by force of contact with the artery wall do not have the metal beads contacting each other. Thus, only the portions of the electrode cover that are deformed inward by artery wall contact conduct energy for ablation, and the remainder of the cover does not conduct energy to the blood.

In some embodiments, a deformable electrode cover includes inner and outer conductive layers separated by an insulating gel that is displaced where the electrode cover contacts the artery wall. The outer conductive layer can include a grid of conductive material separated by insulating material to isolate portions of the outer conductive layer from each other. The power and cooling requirements are greatly reduced by only conducting the ablative energy where it is useful.

Various embodiments of the disclosure are directed to an anisotropic conductive covering for an electrode configured to deliver ablative energy to target tissue of the body, such as perivascular renal nerves. According to some embodiments, an RF electrode includes a thin shell mounted outside, but not touching, an inner electrode. The thin shell comprises conductive elements which are electrically insulated from each other. The conductive elements are oriented across the thickness of the shell, providing electrical continuity between the inside and outside of the shell, but not along the length or perimeter of the shell. When the deformable electrode cover is pressed against the artery wall, the contacting side of the shell is displaced until the inside of the shell contacts the inner electrode. The conductive elements that contact the inner electrode pass current to the outside of the shell and the artery wall, and other portions of the shell that are not displaced inward by force of contact with the artery wall do not contact the inner electrode. Thus, only the portions of the shell that are displaced inward by artery wall contact conduct energy for ablation, and the remainder of the shell does not conduct energy to the blood, resulting in greatly reduced power and cooling requirements.

It is to be understood that when a segment or portion of an electrode cover is described as being “conductive” or “non-conductive,” or as “preventing” conduction, etc., such description is intended to mean that there is a substantial difference in conductivity of force-activated segments and non-force-activated segments of the electrode cover, so that current preferentially flows through the intended segments, even if the conductivity or impedance characteristics of the segments are less than ideal or optimum.

Various embodiments of the disclosure are directed to apparatuses and methods for renal denervation for treating hypertension. Hypertension is a chronic medical condition in which the blood pressure is elevated. Persistent hypertension is a significant risk factor associated with a variety of adverse medical conditions, including heart attacks, heart failure, arterial aneurysms, and strokes. Persistent hypertension is a leading cause of chronic renal failure. Hyperactivity of the sympathetic nervous system serving the kidneys is associated with hypertension and its progression. Deactivation of nerves in the kidneys via renal denervation can reduce blood pressure, and may be a viable treatment option for many patients with hypertension who do not respond to conventional drugs.

The kidneys are instrumental in a number of body processes, including blood filtration, regulation of fluid balance, blood pressure control, electrolyte balance, and hormone production. One primary function of the kidneys is to remove toxins, mineral salts, and water from the blood to form urine. The kidneys receive about 20-25% of cardiac output through the renal arteries that branch left and right from the abdominal aorta, entering each kidney at the concave surface of the kidneys, the renal hilum.

Blood flows into the kidneys through the renal artery and the afferent arteriole, entering the filtration portion of the kidney, the renal corpuscle. The renal corpuscle is composed of the glomerulus, a thicket of capillaries, surrounded by a fluid-filled, cup-like sac called Bowman's capsule. Solutes in the blood are filtered through the very thin capillary walls of the glomerulus due to the pressure gradient that exists between the blood in the capillaries and the fluid in the Bowman's capsule. The pressure gradient is controlled by the contraction or dilation of the arterioles. After filtration occurs, the filtered blood moves through the efferent arteriole and the peritubular capillaries, converging in the interlobular veins, and finally exiting the kidney through the renal vein.

Particles and fluid filtered from the blood move from the Bowman's capsule through a number of tubules to a collecting duct. Urine is formed in the collecting duct and then exits through the ureter and bladder. The tubules are surrounded by the peritubular capillaries (containing the filtered blood). As the filtrate moves through the tubules and toward the collecting duct, nutrients, water, and electrolytes, such as sodium and chloride, are reabsorbed into the blood.

The kidneys are innervated by the renal plexus which emanates primarily from the aorticorenal ganglion. Renal ganglia are formed by the nerves of the renal plexus as the nerves follow along the course of the renal artery and into the kidney. The renal nerves are part of the autonomic nervous system which includes sympathetic and parasympathetic components. The sympathetic nervous system is known to be the system that provides the bodies “fight or flight” response, whereas the parasympathetic nervous system provides the “rest and digest” response. Stimulation of sympathetic nerve activity triggers the sympathetic response which causes the kidneys to increase production of hormones that increase vasoconstriction and fluid retention. This process is referred to as the renin-angiotensin-aldosterone-system (RAAS) response to increased renal sympathetic nerve activity.

In response to a reduction in blood volume, the kidneys secrete renin, which stimulates the production of angiotensin. Angiotensin causes blood vessels to constrict, resulting in increased blood pressure, and also stimulates the secretion of the hormone aldosterone from the adrenal cortex. Aldosterone causes the tubules of the kidneys to increase the reabsorption of sodium and water, which increases the volume of fluid in the body and blood pressure.

Congestive heart failure (CHF) is a condition that has been linked to kidney function. CHF occurs when the heart is unable to pump blood effectively throughout the body. When blood flow drops, renal function degrades because of insufficient perfusion of the blood within the renal corpuscles. The decreased blood flow to the kidneys triggers an increase in sympathetic nervous system activity (i.e., the RAAS becomes too active) that causes the kidneys to secrete hormones that increase fluid retention and vasorestriction. Fluid retention and vasorestriction in turn increases the peripheral resistance of the circulatory system, placing an even greater load on the heart, which diminishes blood flow further. If the deterioration in cardiac and renal functioning continues, eventually the body becomes overwhelmed, and an episode of heart failure decompensation occurs, often leading to hospitalization of the patient.

FIG. 1 is an illustration of a right kidney 10 and renal vasculature including a renal artery 12 branching laterally from the abdominal aorta 20. In FIG. 1, only the right kidney 10 is shown for purposes of simplicity of explanation, but reference will be made herein to both right and left kidneys and associated renal vasculature and nervous system structures, all of which are contemplated within the context of embodiments of the disclosure. The renal artery 12 is purposefully shown to be disproportionately larger than the right kidney 10 and abdominal aorta 20 in order to facilitate discussion of various features and embodiments of the present disclosure.

The right and left kidneys are supplied with blood from the right and left renal arteries that branch from respective right and left lateral surfaces of the abdominal aorta 20. Each of the right and left renal arteries is directed across the crus of the diaphragm, so as to form nearly a right angle with the abdominal aorta 20. The right and left renal arteries extend generally from the abdominal aorta 20 to respective renal sinuses proximate the hilum 17 of the kidneys, and branch into segmental arteries and then interlobular arteries within the kidney 10. The interlobular arteries radiate outward, penetrating the renal capsule and extending through the renal columns between the renal pyramids. Typically, the kidneys receive about 20% of total cardiac output which, for normal persons, represents about 1200 mL of blood flow through the kidneys per minute.

The primary function of the kidneys is to maintain water and electrolyte balance for the body by controlling the production and concentration of urine. In producing urine, the kidneys excrete wastes such as urea and ammonium. The kidneys also control reabsorption of glucose and amino acids, and are important in the production of hormones including vitamin D, renin and erythropoietin.

An important secondary function of the kidneys is to control metabolic homeostasis of the body. Controlling hemostatic functions include regulating electrolytes, acid-base balance, and blood pressure. For example, the kidneys are responsible for regulating blood volume and pressure by adjusting volume of water lost in the urine and releasing erythropoietin and renin, for example. The kidneys also regulate plasma ion concentrations (e.g., sodium, potassium, chloride ions, and calcium ion levels) by controlling the quantities lost in the urine and the synthesis of calcitrol. Other hemostatic functions controlled by the kidneys include stabilizing blood pH by controlling loss of hydrogen and bicarbonate ions in the urine, conserving valuable nutrients by preventing their excretion, and assisting the liver with detoxification.

Also shown in FIG. 1 is the right suprarenal gland 11, commonly referred to as the right adrenal gland. The suprarenal gland 11 is a star-shaped endocrine gland that rests on top of the kidney 10. The primary function of the suprarenal glands (left and right) is to regulate the stress response of the body through the synthesis of corticosteroids and catecholamines, including cortisol and adrenaline (epinephrine), respectively. Encompassing the kidneys 10, suprarenal glands 11, renal vessels 12, and adjacent perirenal fat is the renal fascia, e.g., Gerota's fascia, (not shown), which is a fascial pouch derived from extraperitoneal connective tissue.

The autonomic nervous system of the body controls involuntary actions of the smooth muscles in blood vessels, the digestive system, heart, and glands. The autonomic nervous system is divided into the sympathetic nervous system and the parasympathetic nervous system. In general terms, the parasympathetic nervous system prepares the body for rest by lowering heart rate, lowering blood pressure, and stimulating digestion. The sympathetic nervous system effectuates the body's fight-or-flight response by increasing heart rate, increasing blood pressure, and increasing metabolism.

In the autonomic nervous system, fibers originating from the central nervous system and extending to the various ganglia are referred to as preganglionic fibers, while those extending from the ganglia to the effector organ are referred to as postganglionic fibers. Activation of the sympathetic nervous system is effected through the release of adrenaline (epinephrine) and to a lesser extent norepinephrine from the suprarenal glands 11. This release of adrenaline is triggered by the neurotransmitter acetylcholine released from preganglionic sympathetic nerves.

The kidneys and ureters (not shown) are innervated by the renal nerves 14. FIGS. 1 and 2A-2B illustrate sympathetic innervation of the renal vasculature, primarily innervation of the renal artery 12. The primary functions of sympathetic innervation of the renal vasculature include regulation of renal blood flow and pressure, stimulation of renin release, and direct stimulation of water and sodium ion reabsorption.

Most of the nerves innervating the renal vasculature are sympathetic postganglionic fibers arising from the superior mesenteric ganglion 26. The renal nerves 14 extend generally axially along the renal arteries 12, enter the kidneys 10 at the hilum 17, follow the branches of the renal arteries 12 within the kidney 10, and extend to individual nephrons. Other renal ganglia, such as the renal ganglia 24, superior mesenteric ganglion 26, the left and right aorticorenal ganglia 22, and celiac ganglia 28 also innervate the renal vasculature. The celiac ganglion 28 is joined by the greater thoracic splanchnic nerve (greater TSN). The aorticorenal ganglia 26 is joined by the lesser thoracic splanchnic nerve (lesser TSN) and innervates the greater part of the renal plexus.

Sympathetic signals to the kidney 10 are communicated via innervated renal vasculature that originates primarily at spinal segments T10-T12 and Ll. Parasympathetic signals originate primarily at spinal segments S2-S4 and from the medulla oblongata of the lower brain. Sympathetic nerve traffic travels through the sympathetic trunk ganglia, where some may synapse, while others synapse at the aorticorenal ganglion 22 (via the lesser thoracic splanchnic nerve, i.e., lesser TSN) and the renal ganglion 24 (via the least thoracic splanchnic nerve, i.e., least TSN). The postsynaptic sympathetic signals then travel along nerves 14 of the renal artery 12 to the kidney 10. Presynaptic parasympathetic signals travel to sites near the kidney 10 before they synapse on or near the kidney 10.

With particular reference to FIG. 2A, the renal artery 12, as with most arteries and arterioles, is lined with smooth muscle 34 that controls the diameter of the renal artery lumen 13. Smooth muscle, in general, is an involuntary non-striated muscle found within the media layer of large and small arteries and veins, as well as various organs. The glomeruli of the kidneys, for example, contain a smooth muscle-like cell called the mesangial cell. Smooth muscle is fundamentally different from skeletal muscle and cardiac muscle in terms of structure, function, excitation-contraction coupling, and mechanism of contraction.

Smooth muscle cells can be stimulated to contract or relax by the autonomic nervous system, but can also react on stimuli from neighboring cells and in response to hormones and blood borne electrolytes and agents (e.g., vasodilators or vasoconstrictors). Specialized smooth muscle cells within the afferent arteriole of the juxtaglomerular apparatus of kidney 10, for example, produces renin which activates the angiotension II system.

The renal nerves 14 innervate the smooth muscle 34 of the renal artery wall 15 and extend lengthwise in a generally axial or longitudinal manner along the renal artery wall 15. The smooth muscle 34 surrounds the renal artery circumferentially, and extends lengthwise in a direction generally transverse to the longitudinal orientation of the renal nerves 14, as is depicted in FIG. 2B.

The smooth muscle 34 of the renal artery 12 is under involuntary control of the autonomic nervous system. An increase in sympathetic activity, for example, tends to contract the smooth muscle 34, which reduces the diameter of the renal artery lumen 13 and decreases blood perfusion. A decrease in sympathetic activity tends to cause the smooth muscle 34 to relax, resulting in vessel dilation and an increase in the renal artery lumen diameter and blood perfusion. Conversely, increased parasympathetic activity tends to relax the smooth muscle 34, while decreased parasympathetic activity tends to cause smooth muscle contraction.

FIG. 3A shows a segment of a longitudinal cross-section through a renal artery, and illustrates various tissue layers of the wall 15 of the renal artery 12. The innermost layer of the renal artery 12 is the endothelium 30, which is the innermost layer of the intima 32 and is supported by an internal elastic membrane. The endothelium 30 is a single layer of cells that contacts the blood flowing though the vessel lumen 13. Endothelium cells are typically polygonal, oval, or fusiform, and have very distinct round or oval nuclei. Cells of the endothelium 30 are involved in several vascular functions, including control of blood pressure by way of vasoconstriction and vasodilation, blood clotting, and acting as a barrier layer between contents within the lumen 13 and surrounding tissue, such as the membrane of the intima 32 separating the intima 32 from the media 34, and the adventitia 36. The membrane or maceration of the intima 32 is a fine, transparent, colorless structure which is highly elastic, and commonly has a longitudinal corrugated pattern.

Adjacent the intima 32 is the media 33, which is the middle layer of the renal artery 12. The media is made up of smooth muscle 34 and elastic tissue. The media 33 can be readily identified by its color and by the transverse arrangement of its fibers. More particularly, the media 33 consists principally of bundles of smooth muscle fibers 34 arranged in a thin plate-like manner or lamellae and disposed circularly around the arterial wall 15. The outermost layer of the renal artery wall 15 is the adventitia 36, which is made up of connective tissue. The adventitia 36 includes fibroblast cells 38 that play an important role in wound healing.

A perivascular region 37 is shown adjacent and peripheral to the adventitia 36 of the renal artery wall 15. A renal nerve 14 is shown proximate the adventitia 36 and passing through a portion of the perivascular region 37. The renal nerve 14 is shown extending substantially longitudinally along the outer wall 15 of the renal artery 12. The main trunk of the renal nerves 14 generally lies in or on the adventitia 36 of the renal artery 12, often passing through the perivascular region 37, with certain branches coursing into the media 33 to enervate the renal artery smooth muscle 34.

Embodiments of the disclosure may be implemented to provide varying degrees of denervation therapy to innervated renal vasculature. For example, embodiments of the disclosure may provide for control of the extent and relative permanency of renal nerve impulse transmission interruption achieved by denervation therapy delivered using a treatment apparatus of the disclosure. The extent and relative permanency of renal nerve injury may be tailored to achieve a desired reduction in sympathetic nerve activity (including a partial or complete block) and to achieve a desired degree of permanency (including temporary or irreversible injury).

Returning to FIGS. 3B and 3C, the portion of the renal nerve 14 shown in FIGS. 3B and 3C includes bundles 14 a of nerve fibers 14 b each comprising axons or dendrites that originate or terminate on cell bodies or neurons located in ganglia or on the spinal cord, or in the brain. Supporting tissue structures 14 c of the nerve 14 include the endoneurium (surrounding nerve axon fibers), perineurium (surrounds fiber groups to form a fascicle), and epineurium (binds fascicles into nerves), which serve to separate and support nerve fibers 14 b and bundles 14 a. In particular, the endoneurium, also referred to as the endoneurium tube or tubule, is a layer of delicate connective tissue that encloses the myelin sheath of a nerve fiber 14 b within a fasciculus.

Major components of a neuron include the soma, which is the central part of the neuron that includes the nucleus, cellular extensions called dendrites, and axons, which are cable-like projections that carry nerve signals. The axon terminal contains synapses, which are specialized structures where neurotransmitter chemicals are released in order to communicate with target tissues. The axons of many neurons of the peripheral nervous system are sheathed in myelin, which is formed by a type of glial cell known as Schwann cells. The myelinating Schwann cells are wrapped around the axon, leaving the axolemma relatively uncovered at regularly spaced nodes, called nodes of Ranvier. Myelination of axons enables an especially rapid mode of electrical impulse propagation called saltation.

In some embodiments, a treatment apparatus of the disclosure may be implemented to deliver denervation therapy that causes transient and reversible injury to renal nerve fibers 14 b. In other embodiments, a treatment apparatus of the disclosure may be implemented to deliver denervation therapy that causes more severe injury to renal nerve fibers 14 b, which may be reversible if the therapy is terminated in a timely manner. In preferred embodiments, a treatment apparatus of the disclosure may be implemented to deliver denervation therapy that causes severe and irreversible injury to renal nerve fibers 14 b, resulting in permanent cessation of renal sympathetic nerve activity. For example, a treatment apparatus may be implemented to deliver a denervation therapy that disrupts nerve fiber morphology to a degree sufficient to physically separate the endoneurium tube of the nerve fiber 14 b, which can prevent regeneration and re-innervation processes.

By way of example, and in accordance with Seddon's classification as is known in the art, a treatment apparatus of the disclosure may be implemented to deliver a denervation therapy that interrupts conduction of nerve impulses along the renal nerve fibers 14 b by imparting damage to the renal nerve fibers 14 b consistent with neruapraxia. Neurapraxia describes nerve damage in which there is no disruption of the nerve fiber 14 b or its sheath. In this case, there is an interruption in conduction of the nerve impulse down the nerve fiber, with recovery taking place within hours to months without true regeneration, as Wallerian degeneration does not occur. Wallerian degeneration refers to a process in which the part of the axon separated from the neuron's cell nucleus degenerates. This process is also known as anterograde degeneration. Neurapraxia is the mildest form of nerve injury that may be imparted to renal nerve fibers 14 b by use of a treatment apparatus according to embodiments of the disclosure.

A treatment apparatus may be implemented to interrupt conduction of nerve impulses along the renal nerve fibers 14 b by imparting damage to the renal nerve fibers consistent with axonotmesis. Axonotmesis involves loss of the relative continuity of the axon of a nerve fiber and its covering of myelin, but preservation of the connective tissue framework of the nerve fiber. In this case, the encapsulating support tissue 14 c of the nerve fiber 14 b is preserved. Because axonal continuity is lost, Wallerian degeneration occurs. Recovery from axonotmesis occurs only through regeneration of the axons, a process requiring time on the order of several weeks or months. Electrically, the nerve fiber 14 b shows rapid and complete degeneration. Regeneration and re-innervation may occur as long as the endoneural tubes are intact.

A treatment apparatus may be implemented to interrupt conduction of nerve impulses along the renal nerve fibers 14 b by imparting damage to the renal nerve fibers 14 b consistent with neurotmesis. Neurotmesis, according to Seddon's classification, is the most serious nerve injury in the scheme. In this type of injury, both the nerve fiber 14 b and the nerve sheath are disrupted. While partial recovery may occur, complete recovery is not possible. Neurotmesis involves loss of continuity of the axon and the encapsulating connective tissue 14 c, resulting in a complete loss of autonomic function, in the case of renal nerve fibers 14 b. If the nerve fiber 14 b has been completely divided, axonal regeneration causes a neuroma to form in the proximal stump.

A more stratified classification of neurotmesis nerve damage may be found by reference to the Sunderland System as is known in the art. The Sunderland System defines five degrees of nerve damage, the first two of which correspond closely with neurapraxia and axonotmesis of Seddon's classification. The latter three Sunderland System classifications describe different levels of neurotmesis nerve damage.

The first and second degrees of nerve injury in the Sunderland system are analogous to Seddon's neurapraxia and axonotmesis, respectively. Third degree nerve injury, according to the Sunderland System, involves disruption of the endoneurium, with the epineurium and perineurium remaining intact. Recovery may range from poor to complete depending on the degree of intrafascicular fibrosis. A fourth degree nerve injury involves interruption of all neural and supporting elements, with the epineurium remaining intact. The nerve is usually enlarged. Fifth degree nerve injury involves complete transection of the nerve fiber 14 b with loss of continuity.

FIG. 4 illustrates various processes involving ablation of target tissue of the body in accordance with embodiments of the disclosure. The ablation method shown in FIG. 4 involves situating 102 an ablation electrode having a force-responsive conductive cover within a target vessel of the body, such as a renal artery. The method involves pushing 104 the electrode against the vessel wall so that a region of the electrode cover deforms at a treatment site. Electrical energy is conducted 106 from the electrode to target tissue proximate the treatment site only along a current path that includes the deformed region of the electrode cover. Target tissue, such as perivascular renal nerves, proximate the deformed region of the electrode cover is ablated 108.

FIG. 5 illustrates a portion of a covered electrode 220 situated at a distal end of an ablation catheter in accordance with various embodiments. The catheter, such as that shown in FIG. 12, includes a flexible shaft having a proximal end, a distal end, and a length sufficient to access a target vessel of the body, such as a patient's renal artery. The catheter includes a conductor arrangement that extends along the shaft between the proximal and distal ends. The covered electrode 220 shown in FIG. 5 is preferably situated at the end of the catheter's shaft and coupled to the conductor arrangement. The covered electrode 220 is dimensioned for deployment within the target vessel. The covered electrode 220 includes a metallic electrode 220 and a deformable cover 201 that encompasses at least part of the electrode 220 and incorporates a force-activatable conduction apparatus 203.

The electrode cover 201 is formed from materials that deform in response to forced engagement with a wall of a target vessel. The force-activatable conduction apparatus 203 is responsive to deformation that occurs at one or more regions of the cover 201 when forced against the wall of the target vessel. Forcible contact between one or more cover regions and the target vessel wall causes the force-activatable conduction apparatus 203 to operate in a conducting state, allowing ablative energy to conduct only through the deformed regions of the cover 201 and into the target tissue. In response to separation between the cover 201 and target vessel wall, the force-activatable conduction apparatus 203 operates in a non-conducting state, by which no ablative energy is conducted through the cover 201.

In the embodiment shown in FIG. 5, the force-activatable conduction apparatus 203 includes a multiplicity of segments 203 _(N) distributed on the deformable cover 201. Each of the segments 203 _(N), as best seen in FIGS. 6A and 6B, is operable in a conducting state and a non-conducting state. Each of the segments 203 _(N) includes semiconductor and insulating material arranged relative to electroactive material to define a force-activated transistor-like structure. Insulating material is arranged between adjacent segments 203 _(N) to prevent electrical conduction between the segments 203 _(N). The electroactive material of each segment 203 _(N) generates a voltage that enables conduction of electrical energy from the electrode 220, through the activated segment 203 _(N), and to target tissue, such as perivascular renal nerves, proximate the activated segment 203 _(N). Removal of a compressive force acting on the segment 203 _(N) causes the segment 203 _(N) to transition to a non-conducting state, thereby preventing conduction of electrical energy from the electrode 220 through the deformable cover 201.

FIG. 6A is a cross-sectional illustration of a single segment 203 _(N) of a force-activatable conduction apparatus 203 incorporated in a deformable electrode cover 201 in accordance with various embodiments. The ablation electrode 220 and electrode cover 201 are shown situated at a distal end of a catheter's shaft 204 and positioned within the lumen of a target vessel 12, with the electrode cover 201 set back from the wall 12 a of the vessel 12. The force-activatable conduction segment 203 _(N) shown in FIG. 6A is in a non-conducting state. Target perivascular renal nerves 14 are shown within perivascular space adjacent the renal artery 12.

The semiconductor, insulating, and electroactive materials of the segment 203 _(N) are arranged to define an inner collector layer 202 electrically coupled to the electrode 220, an outer emitter layer 208, and a base (control) layer 206 electrically coupled to the electroactive layer 204. The electroactive layer 204 is formed from force-sensitive material that, when subject to a mechanical force (e.g., compression), generates a voltage which is seen at the base layer 206. The presence and absence of a voltage at the base layer 206 causes the force-activatable conduction segment 203 _(N) to operate in a conducting state and a non-conducting state, respectively. It is noted that changing the semiconductor material can result in a change in the voltage state that enables and disables conduction.

In accordance with other embodiments, various semiconductor materials and structures can be used to form the segments 203 _(N). For example, silicon can be used, but other semiconductor materials such as germanium, gallium arsenide, silicon carbide, indium compounds, or others, can be utilized as appropriate. The semiconductor materials used to form the segments 203 _(N) are typically doped and arranged to form various n-p and p-n junctions. A simple approach of a modified transistor is particularly useful for low-frequency or direct current situations, but analogous structures for higher frequency alternating current situations, including RF, can be formed by use or modification of other solid-state semiconductor elements. For example, MOSFET circuits can be utilized for RF switching; other variations include TRIAC, quadrac, silicon-controlled rectifier, or solid-state relays can be used or adapted for force-activatable conduction control.

The electroactive force-sensitive layer 204 includes materials that transduce force (or displacement) with electrical charge separation. One example is an electroactive polymer, such as PVDF (polyvinylidene fluoride). Other examples include various piezoelectric materials such as PZT (e.g., lead zirconate titanate). The electroactive force-sensitive layer 204 need not form a complete layer in the structure of segments 203 _(N), but has sufficient size to generate the voltage required to control the semiconductor circuit to allow conduction of electricity through segments 203 _(N) of the electrode cover 201. The electroactive force-sensitive layer 204 in each segment 203 _(N) is isolated from each other so that each 203 _(N) is activated independently based on the force applied to that particular segment 203 _(N).

Numerous embodiments of a force activatable conduction apparatus according to FIGS. 5 and 6 are contemplated. Representative embodiments preferably include the following components: multiple segments 203 _(N) which are electrically isolated from each other; an electromechanical transducer element (such as the force-sensitive layer 204) which, when deformed, produces a voltage; and a semiconductor arrangement which passes electrical current (DC and/or AC, depending on the particular situation and the semiconductor arrangement chosen) only while the electromechanical transducer element is exposed to a deflection force. The overall structure functions as an array of switched conductive segments, where force (or displacement) switches individual conductive segments “on,” and removal of such force (or displacement) switches individual conductive segments “off.”

FIG. 6B shows the force-activatable conduction segment 203 _(N) of FIG. 6A in a conducting state. In FIG. 6B, the deformable cover 201 is shown in forced contact with the wall 12 a of a target vessel, such as a renal artery 12. In response to mechanical force transferred from the outer emitter layer 208 to the force-sensitive layer 204, the electroactive material of the force-sensitive layer 204 generates a voltage which is presented at the base (control) layer 206. The voltage developed at the base layer 206 causes current to flow from the electrode 220, through the inner and outer layers 202 and 208, and into the target tissue, which in this illustration includes perivascular renal nerves 14.

Turning now to FIGS. 7 and 8, there is illustrated a covered electrode 300 having deformable cover 301 which incorporates a force-activatable conduction apparatus 303 in accordance with various embodiments. FIG. 7 shows the force-activatable conduction apparatus 303 in a non-conducting state, while FIG. 8 shows the force-activatable conduction apparatus 303 in a conducting state. In the embodiment shown in FIGS. 7 and 8, the force-activatable conduction apparatus 303 includes a multiplicity of conductive particles 304 distributed within a nonconductive matrix 306. When in the non-conducting state, the conductive particles 304 are suspended within the nonconductive matrix 306 in a non-contacting orientation. As such, the insulating matrix 306 disposed between the conductive particles 304 prevents current from flowing through the electrode cover 301 in the absence of a deformation force applied to the cover 301. In some embodiments, the conductive particles 304 can be metal beads, for example, and the nonconductive matrix 306 can be a silicone gel, for example. In some embodiments, the conductive particles 304 may define microspheres having a nonconductive grease-like surface.

The conductive particles 304 are typically metal or other good electrical conductors, but other conductive materials or coated particles could be utilized in some cases. For example, and in accordance with various embodiments, the conductive particles 304 can be formed from the following non-limiting, non-exhaustive list of materials: silver, preferably in the form of an uncured conductive epoxy or ink similar to those used in “flip chip” bonding processes; gold; platinum; stainless steel; carbon, such as graphite; various noble metals due to their lack of an insulating oxide layer; and hydrogels and polyelectrolytes that change conductivity when stressed.

The nonconductive matrix 306 is typically an oil, wax, or grease material with low conductivity, such as silicone oil, but other deformable or fluid materials can be utilized. In some configurations, distilled water or a deformable foam material, for example, can be used. The materials used for the conductive particles 304 and the nonconductive matrix 306 are chosen so that when a force-activatable conduction segment 303 _(N) is no longer exposed to a deflection force, the matrix 306 again surrounds the conductive particles and prevents current from flowing through electrode cover 301. For example, choosing materials with appropriate “wetting” or surface energy properties can be utilized.

Conduction can also be achieved by using materials that have immiscible conducting and non-conducting material, such as copolymers of urethane or latex-like materials that will spontaneously form regions of “like” material (ionic conductive) within a continuous phase of non-conducting polymer. The insulating matrix 306 can comprise a low-conductivity polymer, such as polyethylene, polystryrene, or polybutylene. Conducting regions can comprise an ionically active conductor, such as saline.

As in previous embodiments, the force-activatable conduction apparatus 303 includes a multiplicity of segments 303 _(N) distributed on the deformable cover 301. Each of the segments 303 _(N) is defined by a set of radially spaced-apart conductive particles 304 that extend between the surface of the electrode 220 and an outer surface of the cover 301. It is noted that the conductive particles 304 need not be arranged in a uniform manner within the insulating matrix 306, as is shown in FIGS. 7 and 8. It is further noted that the conductive particles 304 defining a segment 303 _(N) can include axially offset and radially offset neighboring conductive particles 304 suspended in the nonconductive matrix 306.

FIG. 8 shows a region of the force-activatable conduction apparatus 303 of the electrode cover 301 in a conducting state. In FIG. 8, a region R of the deformable cover 301 is subject to a deformation force, F, resulting from forced contact with a wall of a target vessel. When the region R of the electrode cover 301 is subject to the deformation force, F, the set of particles 304 of one or more segments 303 _(N) contact one another and form one or more conduction paths between the electrode 220 and the exterior surface of the deformable cover 301. Current, I, flows from the electrode 220 along the one or more conduction paths, and into target tissue proximate the region R of the deformable cover 301. Generally, the current, I, is high-frequency (e.g., radiofrequency) alternating current developed between the electrode 220 and an electrode situated external of the target vessel, such as at a patient-external location. Because high-frequency ablative energy is conducted to target tissue only through a limited region where the covered ablation electrode 300 contacts the wall of the target vessel, the risk of thermal damage to the non-targeted vessel wall tissue is significantly reduced.

According to the embodiment shown in FIG. 9, a force-activatable conduction apparatus 403 of a deformable electrode cover 401 includes an inner conductive layer 404, an outer conductive layer 402, and a displaceable insulating layer 406 disposed between the inner and outer conductive layers 404 and 402. The outer conductive layer 402 defines a multiplicity of electrically isolated segments 403 _(N). For example, the inner conductive layer 404 can be a continuous conductive layer, and the outer conductive layer 402 can comprise a grid of conductive material segments 403 _(N). Each of the conductive material segments 403 _(N) is surrounded by non-conductive material. The displaceable insulating layer 406 can be an electrically insulating gel, such as silicone gel.

Deformation of a region R of the electrode cover 401 causes displacement of the insulating layer 406 from one or more of the electrically isolated segments 403 _(N) proximate the deformed cover region R. Displacement of the insulating layer 406 causes electrical contact between the isolated outer layer segments 403 _(N) and the inner conductive layer 404 at the deformed cover region R. This electrical contact between the isolated outer layer segments 403 _(N) and the inner conductive layer 404 causes current, I, to flow from the electrode 220, through the isolated segments 403 _(N), and into target tissue proximate the deformed region R of the electrode cover 401.

The conductive inner and outer layers 404 and 402 typically include metal material, although other conductive structural materials can be used. For example, the conducting inner and outer layers 404 and 402 can be formed using any or combinations of the following representative materials: metal film or foil comprising conductive metals such as stainless steel, aluminum, and alloys such as nitinol and chromium steel; and conductive polymers such as poly(acetylene)s, poly(pyrrole)s, poly(thiophene)s, poly(terthiophene)s, poly(aniline)s, poly(fluorine)s, poly(3-alkylthiophene)s, polytetrathiafulvalenes, polynapthalenes, poly(p-phenylene sulfide), poly(pphenylenevinylene)s, poly(3,4-ethylenedioxythiophene), polyparaphenylene, polyazulene, polyparaphenylene sulfide, polycarbazole and polydiaminonaphthalene. In some configurations, metalized polymers can be used if a connection is provided between inner and outer surfaces of a metalized polymer layer 404, 402.

The insulating layer 406 typically includes a non-conductive fluid such as silicone gel, but other non-conductive materials can be used, including urethane, non-ionic water, oils, grease, and aliphatic hydrocarbons. A simple “air gap” filled with gas, or a vacuum can be used for the insulating layer 406. Various non-conductive suspensions can be used for the insulating layer 406. In the case of a force-activatable sub-assembly having a conductive inner layer 404/insulating layer 406/conductive outer layer 402 construction, hydrophobic gels or oils can be used as the insulating layer 406 and be injected into the sub-assembly using a vacuum fill or bleed hole feature during manufacturing.

With reference to FIGS. 8 and 9, there is illustrated covered ablation electrode 500 that includes a deformable electrode cover 501 which incorporates a force-activatable conduction apparatus 503 in accordance with various embodiments. The deformable electrode cover 501 shown in FIGS. 8 and 9 comprises a deformable shell 502 having an inner surface 507 and an outer surface 505. The deformable shell 502 is maintained in a non-contacting relationship with respect to the electrode 220 in the absence of a deformation force applied to the electrode cover 501.

According to some embodiments, a bellows can be incorporated into the proximal part of the shell 502. The bellows can provide both a hermetic seal and an elastic support. In other embodiments, the material of the electrode cover 501 can have an appropriate stiffness to maintain the desired position with respect to the electrode 220. Circumferential stiffening ribs may be provided to maintain circularity. In further embodiments, the deformable shell 502 can be formed with sufficient strength that the end of the shell can be attached to the electrode 220, with an insulating element to prevent electrical conduction at the attachment point.

In various embodiments, mounting of the deformable shell 501 with respect to the electrode 220 can be accomplished using a fluid bearing surface, wherein the fluid is contained within a fixed volume and tends to seek even distribution over the entirety of the surface. In other embodiments, mounting can be accomplished using highly deformable gel materials, such as silicone polymers or starch polymers. In further embodiments, mounting can be accomplished with struts or mechanical structures commonly used in suspension or support arrangements.

The deformable shell 501 includes a multiplicity of conductive elements 506 each extending between the inner surface 507 and the outer surface 505 of the electrode cover 501. An insulating material 504 is disposed between adjacent conductive elements 506. Deformation of a region R of the electrode cover 501 causes the inner surface 507 of the shell 502 at the deformed region R to contact the electrode 220, causing current to flow between the electrode 220, the conductive elements 506 at the deformed region R, and target tissue proximate the deformed region R. Upon removal of the deformation force at region R, the inner surface 507 of the shell 502 moves out of contact with the electrode 220, and the shell 502 assumes its space-apart, non-conducting orientation relative to the electrode 220.

FIG. 12 shows a representative RF renal therapy apparatus 600 in accordance with various embodiments of the disclosure. The apparatus 600 illustrated in FIG. 12 includes external electrode activation circuitry 620 which comprises power control circuitry 622 and timing control circuitry 624. The external electrode activation circuitry 620, which includes an RF generator, is coupled to optional temperature measuring circuitry 628 and may be coupled to an optional impedance sensor 626. A catheter 601 includes a shaft 604 that incorporates a lumen arrangement 605 configured for receiving a variety of components. A delivery sheath 603 or guiding catheter may be used to facilitate advancement of the catheter 601 into the arterial system via a percutaneous access site 606 and positioning within a target vessel, such as a renal artery 12.

The RF generator of the external electrode activation circuitry 620 may include a pad electrode 630 configured to comfortably engage the patient's back or other portion of the skin near the kidneys. Radiofrequency energy produced by the RF generator is coupled to the electrode arrangement 609 at the distal end of the catheter 601 by the conductor arrangement disposed in the lumen of the catheter's shaft 604. The electrode arrangement 609 is intended to represent any of the covered electrode arrangement embodiments described hereinabove.

Renal denervation therapy using the apparatus shown in FIG. 12 is typically performed using the covered electrode arrangement 609 positioned within the renal artery 12 and the pad electrode 630 positioned on the patient's back near the kidneys, with the RF generator operating in a monopolar mode. In this implementation, the electrode arrangement 609 is configured for operation in a unipolar configuration. The radiofrequency energy flows through deformed regions of the covered electrode arrangement 609 in accordance with a predetermined activation sequence causing ablative heating in the adjacent perivascular renal tissue of the renal artery. In general, when perivascular renal artery tissue temperatures rise above about 113° F. (50° C.), protein is permanently damaged (including those of renal nerve fibers). If heated over about 65° C., collagen denatures and tissue shrinks If heated over about 65° C. and up to 100° C., cell walls break and oil separates from water. Above about 100° C., tissue desiccates.

According to some embodiments, the electrode activation circuitry 620 is configured to control activation and deactivation of the electrode arrangement 609 at the deformed electrode cover regions in accordance with a predetermined energy delivery protocol and in response to signals received from temperature measuring circuitry 628. Thermocouples or other sensors can be incorporated at the electrode arrangement 609 in accordance with various embodiments. For example, a number of thermocouples can be distributed within the cover or shell structure or on the electrode. The thermocouples can provide site-specific temperature information at cover/shell locations that deform and conduct electrical energy due to forcible contact between the cover/shell and the wall of the renal artery or other vessel. The electrode activation circuitry 620 controls radiofrequency energy delivered to the conductive elements of the electrode arrangement 609 at the deformed cover region so as to maintain the current densities at a level sufficient to cause heating of the target tissue preferably to a temperature of at least about 55° C.

In some embodiments, one or more temperature sensors are situated at the electrode arrangement 609 and provide for continuous monitoring of renal artery tissue temperatures, and RF generator power is automatically adjusted so that the target temperatures are achieved and maintained. An impedance sensor arrangement 626 may be used to measure and monitor electrical impedance during RF denervation therapy, and the power and timing of the RF generator 620 may be moderated based on the impedance measurements or a combination of impedance and temperature measurements.

Marker bands 614 can be placed on one or multiple parts of the ablation catheter 601, such as at the electrode arrangement 609, to enable visualization during the procedure. Other portions of the ablation catheter and/or delivery system, such as one or more portions of the shaft (e.g., at an optional hinge mechanism 656), may include a marker band 614. The marker bands 614 may be solid or split bands of platinum or other radiopaque metal, for example. Radiopaque materials are understood to be materials capable of producing a relatively bright or high-contrast image on a fluoroscopy screen or another imaging technique during a medical procedure. This relatively bright image aids the user in determining specific portions of the catheter 601, such as the tip of the catheter 601 or portions of the electrode arrangement 609, and the hinge 656, for example. A braid and/or electrode elements of the catheter 601, according to some embodiments, can be radiopaque. Other imaging aids can be incorporated to enhance the use of other imaging modalities such as ultrasound or MRI, for example.

Various embodiments disclosed herein are generally described in the context of ablation of perivascular renal nerves for control of hypertension. It is understood, however, that embodiments of the disclosure have applicability in other contexts, such as performing ablation from within other vessels of the body, including other arteries, veins, and vasculature (e.g., cardiac and urinary vasculature and vessels), and other tissues of the body, including various organs.

It is to be understood that even though numerous characteristics of various embodiments have been set forth in the foregoing description, together with details of the structure and function of various embodiments, this detailed description is illustrative only, and changes may be made in detail, especially in matters of structure and arrangements of parts illustrated by the various embodiments to the full extent indicated by the broad general meaning of the terms in which the appended claims are expressed. 

1. An apparatus, comprising: a catheter comprising a flexible shaft having a proximal end, a distal end, and a length sufficient to access a patient's renal artery relative to a percutaneous access location; a conductor arrangement extending along the shaft between the proximal and distal ends of the shaft; an electrode provided at the distal end of the shaft, coupled to the conductor arrangement, and dimensioned for deployment within the renal artery; and a deformable cover provided at the electrode and comprising a force-activatable conduction apparatus, the cover configured to prevent conduction of electrical energy through the cover in the absence of cover deformation, and to conduct electrical energy only through a region or regions of the cover subject to deformation, the electrical energy sufficient to ablate perivascular renal nerves proximate the deformed region or regions of the cover.
 2. The apparatus of claim 1, wherein: the force-activatable conduction apparatus comprises a plurality of segments distributed on the deformable cover; each of the segments comprises semiconductor material and insulating material arranged relative to electroactive material to define a force-activated solid-state switching structure; and the electroactive material of each segment generates a voltage that causes conduction of electrical energy from the electrode, through the segment, and to perivascular renal nerves proximate the segment when the electroactive layer is force-activated.
 3. The apparatus of claim 1, wherein: the force-activatable conduction apparatus comprises a plurality of segments distributed on the deformable cover; each of the segments comprises semiconductor material and insulating material arranged relative to an electroactive layer to define an inner collector layer electrically coupled to the electrode, an outer emitter layer, and a base layer electrically coupled to the electroactive layer; the electroactive layer is configured to generate a voltage that is communicated to the base layer in response to a mechanical force transferred to the electroactive layer; and the base layer of each segment is configured to cause current to flow from the electrode, through the segment, and to perivascular renal nerves proximate the segment when the electroactive layer is force-activated.
 4. The apparatus of claim 1, wherein: the force-activatable conduction apparatus comprises a plurality of conductive particles distributed within a nonconductive matrix and in a non-contacting relationship in the absence of cover deformation; and deformation of a region of the cover causes displacement of the nonconductive matrix from a set of conductive particles proximate the deformed cover region, allowing the set of conductive particles to contact one another and conduct electrical energy from the electrode, through the deformed cover region, and into perivascular renal nerves proximate the deformed cover region.
 5. The apparatus of claim 4, wherein the nonconductive matrix comprises a silicone gel.
 6. The apparatus of claim 1, wherein the force-activatable conduction apparatus comprises: an inner conductive layer; an outer conductive layer defining a plurality of electrically isolated segments; and a displaceable insulating layer disposed between the inner and outer conductive layers.
 7. The apparatus of claim 6, wherein the outer conductive layer comprises a grid of conductive material each surrounded by non-conductive material, the grid of isolated conductive material defining the plurality of electrically isolated segments.
 8. The apparatus of claim 6, wherein the displaceable insulating layer comprises an electrically insulating gel.
 9. The apparatus of claim 6, wherein deformation of a region of the cover causes displacement of the insulating layer from one or more of the electrically isolated segments proximate the deformed cover region, allowing conduction of electrical energy from the electrode, through the one or more of the electrically isolated segments proximate the deformed cover region, and into perivascular renal nerves proximate the deformed cover region.
 10. The apparatus of claim 1, wherein the cover comprises a deformable shell having an inner surface and an outer surface, the inner surface of the deformable shell arranged in a non-contacting relationship with the electrode in the absence of cover deformation and comprising: a plurality of conductive elements extending from the inner surface to the outer surface of the shell; and an insulating material disposed between adjacent ones of the plurality of conductive elements.
 11. The apparatus of claim 10, wherein: deformation of a region of the shell causes conductive elements of the plurality of conductive elements proximate the deformed shell region to contact the electrode, allowing conduction of electrical energy from the electrode, through conductive elements of the deformed shell region, and into perivascular renal nerves proximate the deformed shell region.
 12. An apparatus, comprising: a catheter comprising a flexible shaft having a proximal end, a distal end, and a length sufficient to access a target vessel of the body relative to a percutaneous access location; a conductor arrangement extending along the shaft between the proximal and distal ends of the shaft; an electrode provided at the distal end of the shaft, coupled to the conductor arrangement, and dimensioned for deployment within the target vessel; and a deformable cover provided at the electrode and comprising a force-activatable conduction apparatus, the cover configured to prevent conduction of electrical energy through the cover in the absence of cover deformation, and to conduct electrical energy only through a region or regions of the cover subject to deformation, the electrical energy sufficient to ablate target tissue proximate the deformed region or regions of the cover.
 13. The apparatus of claim 12, wherein: the force-activatable conduction apparatus comprises a plurality of segments distributed on the deformable cover; each of the segments comprising semiconductor material and insulating material arranged relative to electroactive material to define a force-activated solid-state switching structure; and the electroactive material of each segment generating a voltage that facilitates conduction of electrical energy from the electrode, through the segment, and to target tissue proximate the segment when the electroactive layer is force-activated.
 14. The apparatus of claim 13, wherein deformation of a region of the cover causes displacement of the insulating layer from one or more of the electrically isolated segments proximate the deformed cover region, allowing conduction of electrical energy from the electrode, through the one or more of the electrically isolated segments proximate the deformed cover region, and into target tissue proximate the deformed cover region
 15. The apparatus of claim 12, wherein: the force-activatable conduction apparatus comprises a plurality of conductive particles distributed within a nonconductive matrix and in a non-contacting relationship in the absence of cover deformation; and deformation of a region of the cover causes displacement of the nonconductive matrix from a set of conductive particles proximate the deformed cover region, allowing the set of conductive particles to contact one another and conduct electrical energy from the electrode, through the deformed cover region, and into target tissue proximate the deformed cover region.
 16. The apparatus of claim 12, wherein the force-activatable conduction apparatus comprises: an inner conductive layer; an outer conductive layer defining a plurality of electrically isolated segments; and a displaceable insulating layer disposed between the inner and outer conductive layers.
 17. The apparatus of claim 12, wherein the cover comprises a deformable shell having an inner surface and an outer surface, the inner surface of the deformable shell arranged in a non-contacting relationship with the electrode in the absence of cover deformation and comprising: a plurality of conductive elements extending from the inner surface to the outer surface of the shell; and an insulating material disposed between adjacent ones of the plurality of conductive elements.
 18. The apparatus of claim 17, wherein: deformation of a region of the shell causes conductive elements of the plurality of conductive elements proximate the deformed shell region to contact the electrode, allowing conduction of electrical energy from the electrode, through conductive elements of the deformed shell region, and into target tissue proximate the deformed shell region.
 19. A method, comprising: situating an electrode comprising a deformable cover within a target vessel; deforming one or more regions of the cover in response to forcing the cover against a wall of the target vessel; conducting ablative electrical energy only through the one or more deformed cover regions and into target tissue proximate the one or more deformed cover regions; and preventing conduction of ablative electrical energy through the cover in the absence of cover deformation.
 20. The method of claim 19, wherein the target vessel comprises a renal artery, and the target tissue comprises perivascular renal nerves. 